Pfizer Admits To Addiction Risk In Opioid Drug Marketing

opioid drugs | Just Believe Recovery PA

In This Article

Pfizer Admits To Addiction Risk In Marketing For Opioid Drugs

According to the National Institute of Drug Abuse, around 2.1 million Americans suffer from addiction related to opioid drugs. And since 2000, the Centers for Disease Control and Prevention estimate that nearly 165,000 people have died opioid drugs overdoses.

The biopharmaceutical company Pfizer has agreed to disclose in its marketing materials that opioid drugs have a significant risk of addiction. They have also agreed to not promote them for unapproved use, such as long-term chronic pain, according to a statement made by the city of Chicago.

However, Pfizer currently only markets one prescription opioid, Embeda. Actually, Embeda is an abuse-deterrent opioid, containing both the painkiller agonist morphine, and the opioid antagonist, naltrexone.

Allyana Anglim, Pfizer spokesperson:

“The voluntary agreement between Pfizer and the City of Chicago arose in connection with the city’s recent efforts to combat opioid abuse, a goal the company fully supports.”

The Lawsuit

Chicago was the first city to sue manufacturers of opioid drugs. Plaintiffs included Purdue Pharma (responsible for OxyContin), Cephalon, Janssen Pharmaceuticals, Endo Health Solutions, and Actavis.

According to the City of Chicago:

“ knowingly and aggressively marketed these drugs as rarely addictive, while touting benefits that lacked scientific support in order to boost profits.”

In its lawsuit, Chicago stated that in 2012, about 1,100 emergency room visits were related to opioid abuse or overdose.

Purdue Pharma is consistently blamed for the rapid growth of painkiller use abuse nationwide. Their aggressive campaign initially claimed that the long-acting formulation of oxycondone reduced the risk of abuse and addiction.

In 2007, Purdue Pharma pled guilty to criminal charges of misleading physicians and the public about OxyContin’s addictive potential.

Other cities and states, such counties in California and the state of West Virginia, have also sued pharmaceutical manufacturers and distributors for contributing to the opioid epidemic.

Pfizer was not among the companies named in Chicago’s lawsuit, and nothing in their agreement suggests that Pfizer has engaged in sketchy marketing tactics.

Pfizer released a the following statement:

“ pleased to work with the city of Chicago to help address the serious problem of prescription opioid abuse. We support efforts that encourage the safe use and appropriate prescribing of opioids.”

Officials hope that Pfizer’s agreement will lead to similar agreements with other opioid manufacturers in the future.

Currently, biopharmaceutical companies adhere to voluntary standards set by their trade association, the Pharmaceutical Research and Manufacturers of America.

~ G. Nathalee Serrels, M.A., Psychology

Just Believe Recovery is a fully licensed, Joint Commission accredited, comprehensive drug and alcohol treatment center located in Carbondale, Pennsylvania

Let's Connect

🔒 Your information is safe & secure

Sidebar Contact

  • This field is for validation purposes and should be left unchanged.
Crossing The Line | Just Believe Recovery PA
Mental Health

Crossing The Line

We all have a habitual line crosser in our lives. Most of the time it is easy to brush off. However, there are times that

Read More »
What Is Doctor Shopping? | Just Believe Recovery PA
Addiction

What Is Doctor Shopping?

“Doctor shopping” is a term that is defined as the actions of an individual who visits multiple treatment providers or pharmacies in an attempt to

Read More »
Coping Mechanisms for Addiction | Just Believe Recovery Pennsylvania
Addiction

Coping Mechanisms for Addiction

If an individual becomes overwhelmed with life’s problems, such as the loss of a loved one, unemployment, a failing marriage, physical health issues, emotional instability,

Read More »